[HTML][HTML] Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer
AS Ropri, RS DeVaux, J Eng, SV Chittur… - Breast Cancer …, 2021 - Springer
Background Increased breast cancer screening over the past four decades has led to a
substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions …
substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions …
Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer
AS Ropri, RS DeVaux, J Eng… - Breast cancer …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Increased breast cancer screening over the past four decades has led to a
substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions …
substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions …
Cis-acting Super-Enhancer lncRNAs as Biomarkers of Early-Stage Breast Cancer
AS Ropri, R DeVaux, J Eng, SV Chittur, J Herschkowitz - 2021 - researchsquare.com
Background Increased breast cancer screening over the past four decades has led to a
substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions …
substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions …
Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer.
AS Ropri, RS DeVaux, J Eng, SV Chittur… - Breast Cancer …, 2021 - search.ebscohost.com
Abstract < bold> Background: </bold> Increased breast cancer screening over the
past four decades has led to a substantial rise in the diagnosis of ductal carcinoma in situ …
past four decades has led to a substantial rise in the diagnosis of ductal carcinoma in situ …
[PDF][PDF] Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer
AS Ropri - 2022 - scholarsarchive.library.albany.edu
Background Increased breast cancer screening over the past four decades has led to a
substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions …
substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions …
Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer.
AS Ropri, RS DeVaux, J Eng, SV Chittur… - Breast Cancer …, 2021 - go.gale.com
Background Increased breast cancer screening over the past four decades has led to a
substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions …
substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions …
[HTML][HTML] Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer
AS Ropri, RS DeVaux, J Eng… - Breast Cancer …, 2021 - breast-cancer-research …
Increased breast cancer screening over the past four decades has led to a substantial rise in
the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions precede invasive …
the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions precede invasive …
Cis-Acting Super-Enhancer lncRNAs as Biomarkers to Early-Stage Breast Cancer
A Ropri - 2022 - search.proquest.com
Background Increased breast cancer screening over the past four decades has led to a
substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions …
substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions …
[PDF][PDF] Cis-acting Super-Enhancer lncRNAs as Biomarkers of Early-Stage Breast Cancer
AS Ropri, R DeVaux, J Eng, SV Chittur, J Herschkowitz - scholar.archive.org
Background Increased breast cancer screening over the past four decades has led to a
substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions …
substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions …
Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer.
AS Ropri, RS DeVaux, J Eng, SV Chittur… - Breast Cancer …, 2021 - europepmc.org
Background Increased breast cancer screening over the past four decades has led to a
substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions …
substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions …